You are here » Home » Companies » Company Overview » Kerala Ayurveda Ltd

Kerala Ayurveda Ltd.

BSE: 530163 Sector: Health care
NSE: N.A. ISIN Code: INE817B01025
BSE 11:37 | 16 Oct 78.15 6.45
(9.00%)
OPEN

73.00

HIGH

84.45

LOW

73.00

NSE 05:30 | 01 Jan Kerala Ayurveda Ltd
OPEN 73.00
PREVIOUS CLOSE 71.70
VOLUME 43796
52-Week high 120.90
52-Week low 55.15
P/E 35.52
Mkt Cap.(Rs cr) 83
Buy Price 78.15
Buy Qty 191.00
Sell Price 79.00
Sell Qty 1.00
OPEN 73.00
CLOSE 71.70
VOLUME 43796
52-Week high 120.90
52-Week low 55.15
P/E 35.52
Mkt Cap.(Rs cr) 83
Buy Price 78.15
Buy Qty 191.00
Sell Price 79.00
Sell Qty 1.00

Kerala Ayurveda Ltd. (KERALAAYURVEDA) - Company History

Kerala Ayurvedic Pharmacy has emerged as a frontline manufacturer of speciality patent ayurvedic medicines - tussnil, liposem and mathrukalpam. The company has drawn on the rich experience of its parent companies - Kerala Pharmacy and Pensen Drugs and Pharmaceuticals - which were merged in 1992. The company came out with a public issue in Feb.'95 to part-finance its 7-cr expansion-cum-diversification programme which involve, expansion of its existing facilities; to develop a fully integrated health care system, cultivate medicinal plants and market ayurvedic medicines. It also envisions setting up a hospital. A modern facility to manufacture patent medicines, tablets, capsules and syrups, is to be set up at Athani, near Alwaye. The company is in the midst of enhancing the installed capacity at its Athani plant to produce traditional ayurvedic medicines. Moreover, the company proposes to organise and relocate its twelve clinics to cover all the principal districts in Kerala and augment facilities at its clinics in Bombay, Madras, Bangalore and Mangalore. In addition, it is increasing the bed strength of its hospital in Alwaye. Kerala Ayurvedic has won the approval of the Karnataka Toursim Development Department to open a health resort at Bangalore catering exclusively to the high income segments, tourists and NRIs. The company has a well-entrenched presence in several states due to its 75 franchisees and 400 stockists. During the year 1999-2000, the company exported medicines worth Rs. 56.43 lacs to USA, UK, Italy, Malaysia, Holland and Japan. Four new products have been developed during the year and intial reports are quite encouraging. Clinical studies conducted for patent products have established their efficiency and has also been affirmed by ayurvedic doctors for prescription. In Bangalore a new Ayurvedic Health resort has started its operation in March 2001 and the trial run had a good response.The company is planning to develop new methods for rare medicinal plants using biofertilizers.